FDA gives nod to first antipsychotic drug for children

08/22/2007 | Yahoo! · Boston Globe (tiered subscription model), The

The FDA on Wednesday approved the use of Johnson & Johnson's antipsychotic drug Risperdal in children and adolescents with schizophrenia or bipolar disorder. The American Psychiatric Association welcomed the agency's decision, saying it "will encourage federal research agencies to accelerate urgently needed studies of mental disorders in children."

View Full Article in:

Yahoo! · Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX